2026 FDA Public Meeting on Cosmetic Adverse Event Reporting

The 2026 FDA Public Meeting on Cosmetic Adverse Event Reporting is a forthcoming event organized by the U.S. Food and Drug Administration (FDA). This public meeting aims to gather input from stakeholders on the reporting of adverse events associated with cosmetic products.

Key topics to be addressed include the implementation of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which grants the FDA authority to mandate recalls of cosmetic products deemed to pose serious health risks. Discussions will also cover the utilization of the FDA's Adverse Event Reporting System (FAERS) Public Dashboard for Cosmetic Products, a tool designed to enhance transparency by providing real-time access to adverse event data.

The meeting will feature sessions led by FDA officials and industry experts, offering insights into compliance expectations and best practices for adverse event reporting. Attendees will have opportunities to engage in Q&A sessions and participate in panel discussions.

This event is essential for cosmetic manufacturers, regulatory affairs professionals, and legal experts seeking to stay informed about evolving FDA regulations and to ensure adherence to new reporting requirements.